Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Sheel Biotech IPO
Price Band
₹59.0–63.0
Issue Size
₹34.02 Cr
Lot Size
2,000 shares
Min Investment
₹252,000
2 LOTS MIN
GMP
+₹16.0 (25.4%)
Issue Price
₹63.0
Subject to Sauda
₹24300
Paid only if allotted
Sheel Biotech IPO AI Summary
- Sheel Biotech IPO is listed on NSE SME in the Diversified Commercial Services sector.
- Price band: ₹59.0–₹63.0 per share, lot size 2,000 shares (min. investment ₹252,000, 2 lots minimum).
- Subscription window: 30 Sep–03 Oct 2025, listing on 08 Oct 2025.
- Current GMP is +₹16.0 (25.4%), an estimated listing price of ₹79 — unofficial and can change daily.
Sheel Biotech Limited is set to launch its IPO with a price band of ₹59.0 to ₹63.0. The company has shown consistent growth in revenue and profit over recent years, specializing in biotechnology and organic farming. Investors should consider their risk tolerance and investment strategy when evaluating this IPO.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Sheel Biotech IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 03 Oct 2025 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Sheel Biotech IPO Grey Market Premium (GMP) Today
GMP
+₹16.0
GMP %
+25.4%
Est. Listing
₹79.0
Updated: 25 Jul 2026 14:15
About the Company
Incorporated in November 1991, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects. The company grows and supplies various plants for field crops, fruits, vegetables, and ornamentals through tissue culture and organic farming. The company manufactures and maintains greenhouses, provides farmer services, and offers training through FPOs. They also deliver landscaping services to the government and private sectors. The company holds ISO 9001:2015, 14001:2015, and 45001:2018 certifications, reflecting its commitment to quality, environmental responsibility, and safety. The company's Research and Development laboratory is recognized by the Department of Biotechnology (DBT) and the Department of Science and Technology (DST) of the Government of India. Sheel Biotech offers a diverse range of services and products, including: Planting Material: Utilizing tissue culture and hydroponics, the company produces high-quality, disease-free planting materials for various crops such as fruits, floriculture, forestry, and ornamentals. Horticultural Projects: Sheel Biotech designs and implements greenhouses, centers of excellence, integrated packhouses, and other turnkey projects, incorporating modern technologies like climate control, automation, drip irrigation, and fertigation to optimize crop yield and quality. Organic Adoption and Certification: The company assists farmers in transitioning to organic farming by providing adoption and certification services in line with the National Programme for Organic Production (NPOP) and the Participatory Guarantee System (PGS). Farmer Producer Organization (FPO) Management: Sheel Biotech supports the establishment and management of FPOs, offering training, skill development, and market linkage assistance to enhance farmers' access to better services and inputs. Skill Development: The company conducts training programs, seminars, workshops, and exposure trips to educate farmers and agripreneurs on modern agricultural practices and techniques. As of September 12, 2025, the Company has 160 permanent employees on its payroll. Competitive Strength: Skilled in biotechnology, organic farming, and greenhouse management. Offers a wide range of products across agriculture, floriculture, and horticulture. Eco-friendly practices and a focus on organic, sustainable farming.
Company Financials (₹ Cr)
As of 2025-03-31
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 113.28 | 105.95 | 93.89 |
| Total Income | 102.27 | 92.55 | 80.19 |
| Profit After Tax | 10.64 | 10.47 | 5.08 |
| EBITDA | 14.97 | 14.45 | 8.83 |
| NET Worth | 83.85 | 72.69 | 63.54 |
| Reserves and Surplus | 68.90 | 68.58 | 59.40 |
| Total Borrowing | 17.36 | 23.54 | 19.17 |
Key Ratios
EPS
₹7.11
NAV
₹56.84
ROE
13.59%
ROCE
16.34%
RoNW
13.59%
P/B Value
1.11
P/E Ratio
8.86
Market Cap
₹128.22 Cr
PAT Margin
10.45%
Debt/Equity
0.21
Peer Comparison
| Company | P/E (x) | EPS Basic | EPS Diluted | RoNW |
|---|---|---|---|---|
| Vrundavan Plantation Ltd | 14.24 | 3.3 | 3.3 | — |
| Jain Irrigation Systems Limited | 143.97 | 0.36 | 0.36 | — |
| Sheel Biotech Ltd. This IPO | — | 7.21 | 7.21 | 14.45% |
Promoters
Satya Narayan Chandak, Sanjay Chandak, Divye Chandak, Mini Chadha, Satya Narayan Chandak (HUF), Sanjay Chandak (HUF) and Sumeet Chandak (HUF)
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Capital Expenditure Requirement 9.12 2 Working Capital Requirement 15.88 3 General Corporate Purposes 4.77 4 Issue Expense 4.25
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income increased from ₹80.19 Cr in the year ending 31 Mar 2023 to ₹92.55 Cr by 31 Mar 2024, and further rose to ₹102.27 Cr by 31 Mar 2025. This indicates a consistent growth in revenue over the periods.
Profit Trend
Profit after tax rose from ₹5.08 Cr in the year ending 31 Mar 2023 to ₹10.47 Cr by 31 Mar 2024, and further increased to ₹10.64 Cr by 31 Mar 2025. This shows a positive trend in profitability over the observed periods.
Valuation
Sheel Biotech's P/E ratio is 8.86 at the issue price, compared to peers Vrundavan Plantation Ltd at 14.24 and Jain Irrigation Systems Limited at 143.97. This positions Sheel Biotech at a lower valuation relative to its peers.
Grey Market Premium, Explained
The Grey Market Premium (GMP) is an indicator of the expected listing price of an IPO. It reflects the demand for the shares before they are officially listed on the stock exchange. A positive GMP suggests that the stock may list at a higher price than the issue price, while a negative GMP indicates the opposite.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against the company's fundamentals, market conditions, and overall investment strategy.
Who May Want to Wait
Investors who prefer stable returns and are risk-averse may want to avoid IPOs like this, as they can be subject to market fluctuations and uncertainties.
IPO Timeline, Explained
The IPO process includes several key dates: it opens for subscription on 30 September 2025 and closes on 3 October 2025. Allotment of shares will be done on 6 October 2025, with the listing date set for 8 October 2025.
Listing Gains — The Risk
Listing day gains can be unpredictable. While some IPOs may experience significant price increases on their first day of trading, others may not perform as well. Investors should be prepared for the possibility of price volatility.
This evaluation is generated from Sheel Biotech's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Sheel Biotech IPO GMP today?
Sheel Biotech IPO GMP today is +₹16.0 (25.4%), indicating an estimated listing price of ₹79. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Sheel Biotech IPO?
The price band of Sheel Biotech IPO is ₹59.0–₹63.0 per share.
When does Sheel Biotech IPO open and close?
Sheel Biotech IPO opens on 30 September 2025 and closes on 03 October 2025.
When does Sheel Biotech IPO list on the stock exchange?
Sheel Biotech IPO listed on 08 October 2025 at ₹79.0.
What is the lot size for Sheel Biotech IPO?
The lot size for Sheel Biotech IPO is 2000 shares, requiring a minimum investment of ₹252,000 (2 lots).
What is the price band for the Sheel Biotech IPO?
The price band for the Sheel Biotech IPO is ₹59.0 to ₹63.0.
What is the minimum investment required for the Sheel Biotech IPO?
The minimum investment required for the Sheel Biotech IPO is ₹252,000.
What is the lot size for the Sheel Biotech IPO?
The lot size for the Sheel Biotech IPO is 2000 shares.
What does GMP mean?
GMP stands for Grey Market Premium, indicating the expected listing price of an IPO based on demand in the unofficial market.
When is the listing date for the Sheel Biotech IPO?
The listing date for the Sheel Biotech IPO is 8 October 2025.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
30 Sep 2025
Close
03 Oct 2025
Allotment
06 Oct 2025
Listing
08 Oct 2025
Similar IPOs in Diversified Commercial Services
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Sheel Biotech?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.